Cyclothiazide

Jump to: navigation, search
Cyclothiazide
Cyclothiazide.png
Clinical data
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC14H16ClN3O4S2
Molar mass389.88 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

WikiDoc Resources for Cyclothiazide

Articles

Most recent articles on Cyclothiazide

Most cited articles on Cyclothiazide

Review articles on Cyclothiazide

Articles on Cyclothiazide in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cyclothiazide

Images of Cyclothiazide

Photos of Cyclothiazide

Podcasts & MP3s on Cyclothiazide

Videos on Cyclothiazide

Evidence Based Medicine

Cochrane Collaboration on Cyclothiazide

Bandolier on Cyclothiazide

TRIP on Cyclothiazide

Clinical Trials

Ongoing Trials on Cyclothiazide at Clinical Trials.gov

Trial results on Cyclothiazide

Clinical Trials on Cyclothiazide at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cyclothiazide

NICE Guidance on Cyclothiazide

NHS PRODIGY Guidance

FDA on Cyclothiazide

CDC on Cyclothiazide

Books

Books on Cyclothiazide

News

Cyclothiazide in the news

Be alerted to news on Cyclothiazide

News trends on Cyclothiazide

Commentary

Blogs on Cyclothiazide

Definitions

Definitions of Cyclothiazide

Patient Resources / Community

Patient resources on Cyclothiazide

Discussion groups on Cyclothiazide

Patient Handouts on Cyclothiazide

Directions to Hospitals Treating Cyclothiazide

Risk calculators and risk factors for Cyclothiazide

Healthcare Provider Resources

Symptoms of Cyclothiazide

Causes & Risk Factors for Cyclothiazide

Diagnostic studies for Cyclothiazide

Treatment of Cyclothiazide

Continuing Medical Education (CME)

CME Programs on Cyclothiazide

International

Cyclothiazide en Espanol

Cyclothiazide en Francais

Business

Cyclothiazide in the Marketplace

Patents on Cyclothiazide

Experimental / Informatics

List of terms related to Cyclothiazide

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Cyclothiazide (Anhydron, Acquirel, Doburil, Fluidil, Renazide, Tensodiural, Valmiran) is a benzothiadiazide (thiazide) diuretic and antihypertensive that was originally introduced in the United States in 1963 by Eli Lilly and was subsequently also marketed in Europe and Japan.[1][2] Related drugs include diazoxide, hydrochlorothiazide, and chlorothiazide.[3]

In 1993, it was discovered that cyclothiazide is a positive allosteric modulator of the AMPA receptor, capable of reducing or essentially eliminating rapid desensitization of the receptor, and potentiating glutamate currents by as much as 18-fold at the highest concentration tested (100 μM).[3][4][5][6] Additionally, in 2003, cyclothiazide was also found to act as a GABAA receptor negative allosteric modulator, potently inhibiting GABAA-mediated currents.[7] In animals it is a powerful convulsant, robustly enhancing epileptiform activity and inducing seizures, but without producing any apparent neuronal death.[8][9]

References

  1. Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. p. 1932. ISBN 3-88763-075-0.
  2. Sittig, Marshall (1988). Pharmaceutical manufacturing encyclopedia. Park Ridge, N.J., U.S.A: Noyes Publications. p. 1756. ISBN 0-8155-1144-2.
  3. 3.0 3.1 Skolnick, Phil; Palfreyman, Michael G.; Reynolds, Ian J. (1994). Direct and allosteric control of glutamate receptors. Boca Raton: CRC Press. p. 174. ISBN 0-8493-8307-2.
  4. Yamada KA, Tang CM (September 1993). "Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents". Journal of Neuroscience. 13 (9): 3904–15. PMID 8103555.
  5. Bertolino M, Baraldi M, Parenti C; et al. (1993). "Modulation of AMPA/kainate receptors by analogues of diazoxide and cyclothiazide in thin slices of rat hippocampus". Receptors & Channels. 1 (4): 267–78. PMID 7915948.
  6. Ströhle, Andreas; Bilkei-Gorzo, A.; Holsboer, Florian (2005). Anxiety and anxiolytic drugs. Berlin: Springer. p. 566. ISBN 3-540-22568-4.
  7. Deng L, Chen G (October 2003). "Cyclothiazide potently inhibits gamma-aminobutyric acid type A receptors in addition to enhancing glutamate responses". Proceedings of the National Academy of Sciences of the United States of America. 100 (22): 13025–9. doi:10.1073/pnas.2133370100. PMC 240738. PMID 14534329.
  8. Qi J, Wang Y, Jiang M, Warren P, Chen G (March 2006). "Cyclothiazide induces robust epileptiform activity in rat hippocampal neurons both in vitro and in vivo". The Journal of Physiology. 571 (Pt 3): 605–18. doi:10.1113/jphysiol.2005.103812. PMC 1805799. PMID 16423850.
  9. Kong S, Qian B, Liu J, Fan M, Chen G, Wang Y (July 2010). "Cyclothiazide induces seizure behavior in freely moving rats". Brain Research. 1355: 207–213. doi:10.1016/j.brainres.2010.07.088. PMC 2947190. PMID 20678492.

Linked-in.jpg